Abstract | BACKGROUND & AIMS: METHODS: Levels of the novel biomarkers were measured by enzyme-linked immunosorbent assay or real-time quantitative reverse-transcription PCR (qRT-PCR) in two human DILI cohorts: a human volunteer study with acetaminophen and a human immunodeficiency virus (HIV)/ tuberculosis (TB) study. RESULTS: In the acetaminophen study, serum M65 and microRNA-122 levels were significantly increased at an earlier time point than ALT. Furthermore, the maximal elevation of M65 and microRNA-122 exceeded the increase in ALT. In the HIV/TB study, all the analysed novel biomarkers increased after 1 week of treatment. In contrast to ALT, the novel biomarkers remained stable in a human cohort with exercise-induced muscular injury. CONCLUSIONS: M65 and microRNA-122 are potential biomarkers of DILI superior to ALT with respect to sensitivity and specificity.
|
Authors | Petra Thulin, Gunnar Nordahl, Marcus Gry, Getnet Yimer, Eleni Aklillu, Eyasu Makonnen, Getachew Aderaye, Lars Lindquist, C Mikael Mattsson, Björn Ekblom, Daniel J Antoine, B Kevin Park, Stig Linder, Alison H Harrill, Paul B Watkins, Björn Glinghammar, Ina Schuppe-Koistinen |
Journal | Liver international : official journal of the International Association for the Study of the Liver
(Liver Int)
Vol. 34
Issue 3
Pg. 367-78
(Mar 2014)
ISSN: 1478-3231 [Electronic] United States |
PMID | 24118944
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Chemical References |
- Biomarkers
- Keratin-18
- M65 antigen, human
- MIRN122 microRNA, human
- MicroRNAs
- Peptide Fragments
- Alanine Transaminase
|
Topics |
- Alanine Transaminase
(blood)
- Biomarkers
(blood)
- Chemical and Drug Induced Liver Injury
(blood, diagnosis)
- Cohort Studies
- Enzyme-Linked Immunosorbent Assay
- Humans
- Keratin-18
(blood)
- MicroRNAs
(blood)
- Peptide Fragments
(blood)
- Sensitivity and Specificity
|